Case report: 'Photodynamics of Subependymal Giant Cell Astrocytoma with 5-Aminolevulinic acid'.
5-aminolevulinic acid
fluorescence
low grade glioma
minimal invasive parafascicular approach
subependymal giant cell astrocytoma
tuberous sclerosis
Journal
Frontiers in surgery
ISSN: 2296-875X
Titre abrégé: Front Surg
Pays: Switzerland
ID NLM: 101645127
Informations de publication
Date de publication:
2022
2022
Historique:
received:
10
10
2022
accepted:
02
12
2022
entrez:
23
1
2023
pubmed:
24
1
2023
medline:
24
1
2023
Statut:
epublish
Résumé
Subependymal Giant Cell Astrocytoma (SEGA) is a common diagnosis in patients with Tuberous Sclerosis. Although surgical treatment is often required, resection may entail a significant risk for cognitive function given the anatomical relation with critical structures such as the fornices and subgenual area. Therefore, target subtotal resections using minimal invasive approaches focused in the higher metabolic areas are valuable options to preserve quality of life while addressing specific problems caused by the tumor, such as hydrocephalus or progressive growth of a specific component of the tumor. In this report, the authors explore the potential role of 5-ALA in the identification of highly metabolic areas during SEGA resection in the context of minimal invasive approaches.
Identifiants
pubmed: 36684213
doi: 10.3389/fsurg.2022.1065979
pmc: PMC9853524
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1065979Informations de copyright
© 2023 Ghani, Patel, Ghimire, Bodi, Bhangoo, Vergani, Ashkan and Lavrador.
Déclaration de conflit d'intérêts
PG is a Review Editor for Neurosurgery at Frontiers in Surgery.
Références
Oper Neurosurg (Hagerstown). 2020 Jul 1;19(1):1-8
pubmed: 31828346
Rev Neurosci. 2018 Mar 28;29(3):295-301
pubmed: 29211682
Clin Neurol Neurosurg. 2013 Oct;115(10):2075-81
pubmed: 23915916
Acta Neurochir (Wien). 2020 Apr;162(4):813-817
pubmed: 31989247
Pediatr Neurol. 2014 Apr;50(4):307-12
pubmed: 24507694
J Clin Med. 2020 Jul 28;9(8):
pubmed: 32731376
PLoS One. 2013 Oct 18;8(10):e76988
pubmed: 24204718
Neurosurg Focus. 2014 Feb;36(2):E10
pubmed: 24484248
Neurooncol Adv. 2021 Mar 26;3(1):vdab047
pubmed: 34131646
Acta Neuropathol. 2016 Jun;131(6):803-20
pubmed: 27157931
Front Neurol. 2019 Aug 02;10:821
pubmed: 31428037
Pediatr Neurol. 2013 Dec;49(6):439-44
pubmed: 24138953
Neurocirugia (Astur). 2017 Sep - Oct;28(5):251-256
pubmed: 28495088
J Neurosurg. 2015 Sep;123(3):771-80
pubmed: 26140489
Front Neurol. 2019 Jul 03;10:705
pubmed: 31333563
Biomed Res Int. 2014;2014:232561
pubmed: 24804203
Eur J Neurol. 2009 Jun;16(6):691-6
pubmed: 19236458
PLoS One. 2017 Aug 9;12(8):e0180939
pubmed: 28792952
Neurosurgery. 2016 Mar;78(3):401-11; discussion 411
pubmed: 26366972
Cancer. 2010 Mar 15;116(6):1545-52
pubmed: 20108311
Lancet Oncol. 2014 Dec;15(13):1513-1520
pubmed: 25456370
Neurosurg Rev. 2016 Oct;39(4):545-55
pubmed: 26815631